- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03470779
Impact of Combined Psychotherapy and Physiotherapy Group Treatment Program for Survivors of Torture
March 11, 2019 updated by: Jeff Hartman, Northwestern University
A Randomized Controlled Wait-list Pilot Study Examining the Feasibility and Impact of a Combined Psychotherapy and Physiotherapy Group Treatment Program for Survivors of Torture Incarcerated in an Adult Prison in Kurdistan, Iraq
The aim of this study is to assess the impact and feasibility of an interdisciplinary group treatment approach, involving psychotherapy and physiotherapy, with survivors of torture that are incarcerated in a prison in Kurdistan, Iraq.
The primary aim is to develop initial estimates of treatment effects on symptoms and poor functioning consistent with centralized pain and post-traumatic stress disorder, anxiety, and/or depression.
The secondary aim is to assess the feasibility of studying this interdisciplinary treatment program in which local Kurdish psychotherapists and physiotherapists provide a 10-week intervention in a prison, in the Kurdish Sorani language, and to Kurdish participants that present with mental health symptoms, physical complaints, and poor functioning
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The aim of this randomized wait-list controlled pilot study is to assess the impact and feasibility of an interdisciplinary group treatment approach, involving psychotherapy and physiotherapy, with survivors of torture that are incarcerated in a prison in Kurdistan, Iraq.
The primary aim is to develop initial estimates of treatment effects on symptoms and poor functioning consistent with centralized pain and post-traumatic stress disorder, anxiety, and/or depression.
It is hypothesized that participants in the study will present with statistically significant improvements in some to all measures of symptoms and function.
The secondary aim is to assess the feasibility of studying this interdisciplinary treatment program in which local Kurdish psychotherapists and physiotherapists provide a 10-week intervention in a prison, in the Kurdish Sorani language, and to Kurdish participants that present with mental health symptoms, physical complaints, and poor functioning
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Kurdistan
-
Sulaymaniyah, Kurdistan, Iraq
- Sulaymaniyah Adult Male Reformatory
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 100 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Age equal to or greater than 18 years
- Incarcerated in the reformatory where research is conducted
- Native speaker of Sorani, a Kurdish language
- History of torture is reported and documented during the psychotherapy intake
- Presents with symptoms consistent with post-traumatic stress disorder, anxiety, and/or depression evident by a total score of greater than or equal to 1.75 on Hopkins Symptoms Checklist-25 and/or by a total score greater than or equal to 2.5 on the Harvard Trauma Questionnaire Part 4
- Presents with symptoms consistent with centralized pain evident by a score of greater than or equal to 40 on the Central Sensitization Inventory Part A.
Exclusion Criteria:
- Reports he will not remain in the current reformatory for at least 6 months from the onset of the study
- Is unable to make the time commitment required to participate
- Presents with symptoms consistent with a psychiatric condition which makes participation in the study unsafe for himself or others, based on the evaluation by the treating psychotherapist
- Presents with a high risk to self or others which makes participation in the study unsafe for himself or others, based on evaluation by the treating psychotherapist
- Participation is deemed unsafe due to a severe medical condition previously diagnosed by a medical doctor and/or signs/symptoms consistent with a possible medical condition based on the evaluation by the treating physiotherapist, 6.) reports previously receiving treatment by Wchan
- Current substance abuse reported by participant or identified by treating psychotherapist
- Currently receiving mental health services and/or physiotherapy services from other organization
- Reports unresolvable conflict with participant/s enrolled in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Treatment group
Participants randomly assigned to the treatment group will participate in an interdisciplinary treatment program in which local Kurdish psychotherapists and physiotherapists provide a 10-week intervention program.
Treatment will consist of group physiotherapy and group psychotherapy
|
Treatment group participants will participate in weekly group physiotherapy and psychotherapy sessions as part of the standard program procedure.
Treatment group participants will participate in weekly group physiotherapy and psychotherapy sessions as part of the standard program procedure.
|
|
No Intervention: Wait-list group
Participants randomly assigned to the wait-list group will not receive treatment but will participate in outcome data collection for comparison purposes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hopkins Symptom Checklist-25
Time Frame: 10 weeks
|
The HSCL-25 is a 25-question symptom inventory which measures symptoms of anxiety and depression.
|
10 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Specific Functional Scale
Time Frame: 10-weeks
|
This useful questionnaire can be used to quantify activity limitation and measure functional outcome for patients with any orthopaedic condition.
|
10-weeks
|
|
Pittsburgh Sleep Quality Index
Time Frame: 10-weeks
|
The Pittsburgh Sleep Quality Index (PSQI) is an effective instrument used to measure the quality and patterns of sleep in adults.
|
10-weeks
|
|
Patient's Global Impression of Change Scale
Time Frame: 10-weeks
|
The self-report measure Patient Global Impression of Change (PGIC) reflects a patient's belief about the efficacy of treatment
|
10-weeks
|
|
General Self Efficacy Scale
Time Frame: 10-weeks
|
The General Self-Efficacy Scale is a 10-item psychometric scale that is designed to assess optimistic self-beliefs to cope with a variety of difficult demands in life.
|
10-weeks
|
|
Central Sensitization Inventory
Time Frame: 10-weeks
|
This tool was published with the purpose of providing a single self-report instrument that identified symptoms associated with central sensitization and the quantified the degree of those symptoms.
|
10-weeks
|
|
Harvard Trauma Questionnaire Part 4
Time Frame: 10 weeks
|
The Harvard Trauma Questionnaire (HTQ) is a checklist that inquires about a variety of trauma events, as well as the emotional symptoms considered to be uniquely associated with trauma.
|
10 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jeff A Hartman, DPT, MPH, Northwestern University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 19, 2018
Primary Completion (Actual)
November 15, 2018
Study Completion (Actual)
January 1, 2019
Study Registration Dates
First Submitted
March 13, 2018
First Submitted That Met QC Criteria
March 13, 2018
First Posted (Actual)
March 20, 2018
Study Record Updates
Last Update Posted (Actual)
March 13, 2019
Last Update Submitted That Met QC Criteria
March 11, 2019
Last Verified
March 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- STU00206726
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
IPD Plan Description
Still in deliberation
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Disability Physical
-
Assistance Publique - Hôpitaux de ParisTerminatedPhysical Activity | Physical DisabilityFrance
-
The Nethersole School of NursingNot yet recruiting
-
Johns Hopkins UniversityNational Institute on Disability, Independent Living, and Rehabilitation...Recruiting
-
Istanbul Medeniyet UniversityRecruitingPhysical DisabilityTurkey
-
State University of New York - Upstate Medical...Completed
-
Permobil, Inc.Completed
-
University of PittsburghPatient-Centered Outcomes Research InstituteCompletedPhysical DisabilityUnited States
-
Universitaire Ziekenhuizen KU LeuvenCHU UCL NamurCompletedDisability PhysicalBelgium
-
Bezmialem Vakif UniversityCompleted
-
Fatima Jinnah Women UniversityCompletedPhysical DisabilityPakistan
Clinical Trials on Physiotherapy
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedSubacromial Impingement SyndromeTurkey (Türkiye)
-
Hacettepe UniversityCompleted
-
Manchester Metropolitan UniversityCompleted
-
Rigshospitalet, DenmarkThe Association of Danish Physiotherapists Research Fund, Denmark; The Jubilee...CompletedTrismus | Oropharyngeal Cancer | Oral Cavity Carcinoma | Adverse Effect of Radiation TherapyDenmark
-
University of OviedoCompletedParkinson Disease
-
Isra UniversityCompleted
-
Clinique du Sport, Bordeaux MérignacRecruiting
-
Laura RutkauskienėLithuanian University of Health SciencesActive, not recruitingRespiratory InsufficiencyLithuania
-
University of Nove de JulhoUniversidade Federal do CearaCompletedEdema | ParesthesiaBrazil